Literature DB >> 24923631

Moving beyond survival as a measure of success: understanding the patient experience of necrotizing soft-tissue infections.

Timo W Hakkarainen1, Nicole Burkette Ikebata2, Eileen Bulger3, Heather L Evans3.   

Abstract

BACKGROUND: Necrotizing soft tissue infections (NSTIs) represent a devastating spectrum of disease with high case mortality and resource intensive care. Treatment consists of wide surgical debridement and often prolonged periods of intensive care unit care. Major complications are common. The severity of the disease and the aggressive treatment requirements put survivors at risk for significant long-term sequelae related to the trauma of both disease and treatment. Information about the postdischarge impact of NSTIs on survivors is extremely limited. Qualitative approaches are typically used to explore new phenomena and to capture individuals' thoughts, feelings, or interpretations of meaning and process. Therefore, qualitative methods are ideally suited for hypothesis generation to guide future quantitative study and ensure measured outcomes are patient-centered.
MATERIALS AND METHODS: Semistructured interviews were conducted with survivors of NSTIs from a single regional referral center. Stratified purposive sampling was used to select interview candidates based on severity of illness. Descriptive thematic analysis was performed to identify major themes described by the patients.
RESULTS: Interviews with 18 survivors identified three primary domains of experience: (1) individual factors, (2) relational factors, and (3) societal factors. These domains were split into the following two categories: factors effecting the disease process and recovery, and factors that were outcomes of the disease process. Each category yielded between one and seven themes. Themes identified included physical, psychological, relationship, and employment aspects.
CONCLUSIONS: Patient's reported quality of life was significantly affected by their disease and recovery. The results demonstrate that many outcomes of importance for patients are not easily assessed by traditional measures of outcomes. This work illustrates the multidimensional nature of recovery from critical illness, and shows that it represents a massive transition period in the lives of survivors that affects the patient, their family, and the patient's ability to interact with society. Interviews with survivors ensure that the patient voice is heard before developing tools to assess long-term outcomes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Health-related quality of life; Qualitative research

Mesh:

Year:  2014        PMID: 24923631      PMCID: PMC4188731          DOI: 10.1016/j.jss.2014.05.006

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  19 in total

1.  A fate worse than death? Long-term outcome of trauma patients admitted to the surgical intensive care unit.

Authors:  David H Livingston; Tovah Tripp; Carina Biggs; Robert F Lavery
Journal:  J Trauma       Date:  2009-08

2.  Experience with necrotizing fasciitis at a burn care center.

Authors:  Denise P Redman; Bruce Friedman; Edward Law; Joseph M Still
Journal:  South Med J       Date:  2003-09       Impact factor: 0.954

3.  Predicting death in necrotizing soft tissue infections: a clinical score.

Authors:  Daniel A Anaya; Eileen M Bulger; Yong S Kwon; Lillian S Kao; Heather Evans; Avery B Nathens
Journal:  Surg Infect (Larchmt)       Date:  2009-12       Impact factor: 2.150

4.  Treatment of necrotizing soft tissue infections. The need for a new approach.

Authors:  J A Freischlag; G Ajalat; R W Busuttil
Journal:  Am J Surg       Date:  1985-06       Impact factor: 2.565

5.  Quality of life 2-7 years after major trauma.

Authors:  A Ulvik; R Kvåle; T Wentzel-Larsen; H Flaatten
Journal:  Acta Anaesthesiol Scand       Date:  2007-11-13       Impact factor: 2.105

6.  Functional measures at discharge: are they useful predictors of longer term outcomes for trauma registries?

Authors:  Belinda J Gabbe; Pam M Simpson; Ann M Sutherland; Owen D Williamson; Rodney Judson; Thomas Kossmann; Peter A Cameron
Journal:  Ann Surg       Date:  2008-05       Impact factor: 12.969

7.  Posttraumatic stress disorder and pain impact functioning and disability after major burn injury.

Authors:  Nida H Corry; Brendan Klick; James A Fauerbach
Journal:  J Burn Care Res       Date:  2010 Jan-Feb       Impact factor: 1.845

8.  Long-term outcomes of patients with necrotizing fasciitis.

Authors:  Timothy D Light; Kent C Choi; Timothy A Thomsen; Dionne A Skeete; Barbara A Latenser; Janelle M Born; Robert W Lewis; Lucy A Wibbenmeyer; Nariankadu D Shyamalkumar; Charles F Lynch; Gerald P Kealey
Journal:  J Burn Care Res       Date:  2010 Jan-Feb       Impact factor: 1.845

9.  Assessment of functional limitation after necrotizing soft tissue infection.

Authors:  Tam N Pham; Merilyn L Moore; Beth A Costa; Joseph Cuschieri; Matthew B Klein
Journal:  J Burn Care Res       Date:  2009 Mar-Apr       Impact factor: 1.845

10.  Health related quality of life in trauma patients. Data from a one-year follow up study compared with the general population.

Authors:  Kirsti Tøien; Inger S Bredal; Laila Skogstad; Hilde Myhren; Oivind Ekeberg
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-04-08       Impact factor: 2.953

View more
  8 in total

1.  Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial.

Authors:  Martin B Madsen; Peter B Hjortrup; Marco B Hansen; Theis Lange; Anna Norrby-Teglund; Ole Hyldegaard; Anders Perner
Journal:  Intensive Care Med       Date:  2017-04-18       Impact factor: 17.440

Review 2.  Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes.

Authors:  Timo W Hakkarainen; Nicole M Kopari; Tam N Pham; Heather L Evans
Journal:  Curr Probl Surg       Date:  2014-06-12       Impact factor: 1.909

3.  Patient's characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study.

Authors:  Martin Bruun Madsen; Steinar Skrede; Anders Perner; Per Arnell; Michael Nekludov; Trond Bruun; Ylva Karlsson; Marco Bo Hansen; Peter Polzik; Morten Hedetoft; Anders Rosén; Edoardo Saccenti; François Bergey; Vitor A P Martins Dos Santos; Anna Norrby-Teglund; Ole Hyldegaard
Journal:  Intensive Care Med       Date:  2019-08-22       Impact factor: 17.440

4.  A 5-Year Evaluation of the Implementation of Triple Diagnostics for Early Detection of Severe Necrotizing Soft Tissue Disease: A Single-Center Cohort Study.

Authors:  Femke Nawijn; Roderick M Houwert; Karlijn P J van Wessem; Rogier K J Simmermacher; Geertje A M Govaert; Marijke R van Dijk; Mirjam B de Jong; Ivar G J de Bruin; Luke P H Leenen; Falco Hietbrink
Journal:  World J Surg       Date:  2019-08       Impact factor: 3.352

5.  Outcomes of β-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance.

Authors:  Dara L Horn; Emma A Roberts; Jolie Shen; Jeannie D Chan; Eileen M Bulger; Noel S Weiss; John B Lynch; Chloe Bryson-Cahn; Bryce R H Robinson
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

6.  Survival and Health-Related Quality of Life after Hospitalization for Necrotizing Soft Tissue Infections of the Upper Extremity: A Long-Term Outcome Study.

Authors:  Femke Nawijn; Svenna H W L Verhiel; Juliette Nierich; Kyle R Eberlin; Falco Hietbrink; Neal C Chen
Journal:  J Hand Microsurg       Date:  2020-05-06

7.  Triple diagnostics for early detection of ambivalent necrotizing fasciitis.

Authors:  Falco Hietbrink; Lonneke G Bode; Louis Riddez; Luke P H Leenen; Marijke R van Dijk
Journal:  World J Emerg Surg       Date:  2016-10-11       Impact factor: 5.469

8.  Necrotizing fasciitis and the midterm outcomes after survival.

Authors:  Christiane Kruppa; Danial J Hutter; Matthias Königshausen; Jan Gessmann; Thomas A Schildhauer; Marlon O Coulibaly
Journal:  SAGE Open Med       Date:  2019-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.